Not available
Quote | Cytokinetics Incorporated (NASDAQ:CYTK)
Last: | $63.37 |
---|---|
Change Percent: | -0.15% |
Open: | $61.41 |
Close: | $63.37 |
High: | $64.3 |
Low: | $61.37 |
Volume: | 1,232,149 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
News | Cytokinetics Incorporated (NASDAQ:CYTK)
SOUTH SAN FRANCISCO, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced it will host an investor event and conference call on May 13, 2024 at 4:00 PM Western European Summer Time (11:00 AM Eastern Time) to discuss the primary results from SEQUOIA-...
2024-04-26 16:32:49 ET More on Cytokinetics Cytokinetics, Incorporated: Buyout Speculation Persists Cytokinetics: CEO Talks Down Buyout Prospects Cytokinetics releases more data on hypertrophic cardiomyopathy drug aficamten Cytokinetics gains amid renewed tak...
Message Board Posts | Cytokinetics Incorporated (NASDAQ:CYTK)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CYTK News Article - Cytokinetics Releases Inaugural Corporate Responsibility Report | whytestocks | investorshangout | 03/27/2023 7:46:03 PM |
Wow never seen a stock move up from | Cosa | investorshub | 12/14/2022 6:33:40 PM |
Sold at $41. | H2R | investorshub | 12/14/2022 3:01:42 PM |
Sorry to anyone holding here. I hope | Cosa | investorshub | 12/14/2022 3:54:15 AM |
AdCom: 8 to 3 against! | H2R | investorshub | 12/13/2022 11:29:31 PM |
News, Short Squeeze, Breakout and More Instantly...
Cytokinetics Incorporated Company Name:
CYTK Stock Symbol:
NASDAQ Market:
SOUTH SAN FRANCISCO, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced it will host an investo...
SOUTH SAN FRANCISCO, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced it will host an investor event and conference call on May 13, 2024 at 4:00 PM Western European Summer Time (11:00 AM Eastern Time) to discuss the primary results from SEQUOIA-...
SOUTH SAN FRANCISCO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to...